Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

Why Is Gain Therapeutics (GANX) Stock Moving Today?

Gain Therapeutics stock is on the move Wednesday as investors in GANX react to updated clinical trial news from the company.

Why Is Sonendo (SONX) Stock Up 38% Today?

Sonendo stock is on the rise Wednesday despite the medical technology company recently receiving a delisting notice for SONX shares.

Sure Winners: 7 Stocks Set to Outperform in the Next Recession

These titans boast a unique combination of financial resilience, innovative vision, and adaptability that sets them apart in economic adversity.

Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich

Are you looking to invest in biotechnology breakthroughs? Here are three biotech stocks that could make early investors rich.

Why Is Point Biopharma (PNT) Stock Up 84% Today?

Point Biopharma stock is heading higher on Tuesday as investors react to news of Eli Lilly acquiring the shares of PNT for $12.50 each.

7 Speculative Stocks Set to Explode Higher

On the search for high-risk, high-reward opportunities? Consider taking a look at these seven speculative stocks.

Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs

CAR T therapies have major advantages over traditional cancer drugs. Here are three of the best cancer drug stocks set to benefit from CAR T.

3 Massively Undervalued Dividend Stocks to Buy for High Total Returns

These massively undervalued dividend stocks are poised for a strong rally in the next 12 to 15 months. By the end of 2024, these undervalued dividend stocks may indeed deliver 40% to 50% total returns.

TTOO Stock Alert: A Key Investor Just Dumped Another 13 Million Shares

Since Sept. 19, CR Group has sold off 48.34 million shares of TTOO stock. However, the sales could be coming to a stop soon.

3 Promising Biotech Stocks That Will Make Early Investors Rich

Despite their volatility, certain biotech stocks stand out for their innovative approaches and potential game-changing therapies.

Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024

However, pharmaceutical stocks can be expected to eventually rebound. The good news for investors is that many pharma stocks are on sale right now and can be purchased at rock bottom prices.

Stable Giants: 3 Bigwig Biotech Stocks for Consistent Returns

These biotech stocks, Thermo Fisher, Novo Nordisk, and Eli Lilly, will bring consistent returns in the volatile biotech sector.

Why Is Intelligent Bio Solutions (INBS) Stock Down 52% Today?

Intelligent Bio Solutions stock is falling hard on Friday after the company announced details of a share offering for INBS.

Why Is Invitae (NVTA) Stock Up 28% Today?

Invitae stock is on the rise Monday with heavy trading of NVTA despite a lack of news from the medical genetics company this morning.

Futurescape: Betting Big on These 3 Next-Gen Tech Stocks

Amidst this ever-evolving landscape, three companies stand out as beacons of forward-thinking progress and visionary leadership.

Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs

The best drug stocks to buy now are shooting for the moon. These three trailblazers will land among the stars.

Why Is Tonix Pharmaceuticals (TNXP) Stock Down 29% Today?

Tonix Pharmaceuticals stock is taking a beating on Friday after the company revealed details of an offering for TNXP shares.

Why Is OpGen (OPGN) Stock Up 115% Today?

OpGen stock is on the rise Friday with heavy trading after the precision medicine company withdrew a share offering for OPGN.

Why Is Baudax Bio (BXRX) Stock Up 75% Today?

Although Baudax Bio saw significant interest because of its orphan drug designation, BXRX stock must climb a wall of worry.